Brandt, A., Hernández-Arriaga, A., Kehm, R., Sánchez, V., Jin, C. J., Nier, A., . . . Bergheim, I. (2019). Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci Rep.
Chicago Style citaatBrandt, Annette, Angélica Hernández-Arriaga, Richard Kehm, Victor Sánchez, Cheng Jun Jin, Anika Nier, Anja Baumann, Amélia Camarinha-Silva, en Ina Bergheim. "Metformin Attenuates the Onset of Non-alcoholic Fatty Liver Disease and Affects Intestinal Microbiota and Barrier in Small Intestine." Sci Rep 2019.
MLA citatieBrandt, Annette, et al. "Metformin Attenuates the Onset of Non-alcoholic Fatty Liver Disease and Affects Intestinal Microbiota and Barrier in Small Intestine." Sci Rep 2019.